ArticleJournal of gynecologic oncology2020

Clinical response and safety of apatinib monotherapy in recurrent, metastatic cervical cancer after failure of chemotherapy: a retrospective study.

Yan Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.